🇺🇸 FDA
Patent

US 8426433

Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution

granted A61PA61P31/04A61P7/00

Quick answer

US patent 8426433 (Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution) held by Obschestvo S Ogranichennoi Otvetsttvennoctiyu “Bionika” expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Obschestvo S Ogranichennoi Otvetsttvennoctiyu “Bionika”
Grant date
Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P31/04, A61P7/00, A61P7/02, A61P7/08